-
DMD Therapy CAP-1002 Leads to Heart, Skeletal Muscle Benefits in Trial
Treatment with CAP-1002 improved heart and skeletal muscle function, and reduced cardiac scarring in advanced Duchenne patients in a Phase 1/2 trial. Read more about the trial here.
Are you interested in more news about trials like this one?
Sorry, there were no replies found.
Log in to reply.